Masimo ROA - Return on Assets 2010-2025 | MASI

Masimo return on assets for the quarter ending March 31, 2025 was -18.16.

  • Masimo average return on assets for 2024 was -0.64, a 119.45% increase from 2023.
  • Masimo average return on assets for 2023 was 3.29, a 60.6% decline from 2022.
  • Masimo average return on assets for 2022 was 8.35, a 38.15% decline from 2021.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

Masimo ROA - Return on Assets 2010-2025 | MASI

  • Masimo average return on assets for 2024 was -0.64, a 119.45% increase from 2023.
  • Masimo average return on assets for 2023 was 3.29, a 60.6% decline from 2022.
  • Masimo average return on assets for 2022 was 8.35, a 38.15% decline from 2021.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$180.6B
Intuitive Surgical (ISRG)$177.8B
Edwards Lifesciences (EW)$46.9B
IDEXX Laboratories (IDXX)$45.5B
Alcon (ALC)$45.3B
DexCom (DXCM)$34.9B
IQVIA Holdings (IQV)$33.9B
Mettler-Toledo (MTD)$26.3B
STERIS (STE)$22.7B
Waters (WAT)$18B
SONOVA HOLDING (SONVY)$17.5B
Hologic (HOLX)$14.8B
Sysmex ADR (SSMXY)$10.7B
Penumbra (PEN)$9B
Globus Medical (GMED)$7.4B
Glaukos (GKOS)$5.4B
Teleflex (TFX)$5.2B
Integer Holdings (ITGR)$3.8B
TransMedics (TMDX)$3.7B
PROCEPT BioRobotics (PRCT)$3.1B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2.1B
Elekta AB (EKTAY)$2B
Veracyte (VCYT)$2B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Tandem Diabetes Care (TNDM)$1.1B
Integra LifeSciences Holdings (IART)$1B